Norepinephrine Dilution and Titration for 16mg/15mL Preparation in a 75kg Patient
For a 16mg/15mL norepinephrine preparation, dilute the entire 15mL into 235mL of 5% dextrose (D5W) to create a standard 250mL solution with a final concentration of 64 mcg/mL (16,000 mcg ÷ 250mL), then start the infusion at 7.5-37.5 mcg/min (7-35 mL/hr) and titrate to maintain MAP ≥65 mmHg. 1
Dilution Protocol
Diluent Selection:
- Use 5% dextrose in water (D5W) or 5% dextrose with sodium chloride as the primary diluent 1
- Do NOT use normal saline alone - dextrose-containing solutions protect against oxidation and loss of potency 1
- The solution remains chemically stable for 7 days at room temperature under ambient light in either D5W or NS, though D5W is preferred per FDA labeling 2
Standard Dilution Method:
- Add your 15mL (containing 16mg = 16,000 mcg) to 235mL of D5W
- Final volume: 250mL
- Final concentration: 64 mcg/mL (16,000 mcg ÷ 250mL)
This creates a more concentrated solution than the standard FDA-recommended 4 mcg/mL, but remains within acceptable ranges for central line administration 1.
Administration Route
Central venous access is strongly preferred - norepinephrine and other catecholamines cause severe tissue necrosis if extravasation occurs 3. If extravasation develops, immediately infiltrate 5-10mg of phentolamine diluted in 10-15mL saline into the affected site 3, 4.
Titration Protocol for 75kg Patient
Starting Dose:
- Begin at 0.1 mcg/kg/min = 7.5 mcg/min for this 75kg patient 3
- With your 64 mcg/mL concentration: 7 mL/hr delivers approximately 7.5 mcg/min
- Observe response for 2-3 minutes before adjusting 1
Dose Range:
- Initial titration range: 0.1-0.5 mcg/kg/min (7.5-37.5 mcg/min in 75kg patient) 3
- With your concentration, this translates to 7-35 mL/hr
- Adjust rate to establish and maintain MAP ≥65 mmHg 5
Titration Strategy:
- Increase by 2-4 mcg/min increments (approximately 2-4 mL/hr with your concentration) every 2-3 minutes based on blood pressure response 1
- Target MAP of 65 mmHg is the evidence-based goal for most patients 5
- In previously hypertensive patients, avoid raising BP more than 40 mmHg below their baseline systolic pressure 1
High-Dose Considerations:
- Doses may occasionally need to exceed 0.5 mcg/kg/min if hypotension persists 3
- Always suspect occult hypovolemia if requiring escalating doses - ensure adequate volume resuscitation first 1
- Central venous pressure monitoring is helpful for detecting volume depletion 1
Critical Monitoring Parameters
Continuous monitoring required:
- Blood pressure (arterial line preferred for continuous monitoring)
- Heart rate and cardiac rhythm
- Urine output (should achieve >100 mL/hr initially) 6
- Signs of peripheral perfusion (skin temperature, color, capillary refill)
- IV site for extravasation 3
Important Caveats
Volume Status First: Blood volume depletion must be corrected as fully as possible before starting norepinephrine, though it can be given concurrently with volume resuscitation in emergency situations 1.
Weight-Based Dosing Consideration: Recent evidence shows obese patients require lower weight-based doses but similar absolute doses compared to non-obese patients 7. For a 75kg patient of normal BMI, standard weight-based dosing applies.
Compatibility: Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions - adrenergic agents are inactivated in alkaline environments 3. Avoid contact with iron salts, alkalis, or oxidizing agents 1.
Solution Inspection: Discard if solution is pinkish, darker than slightly yellow, or contains precipitate 1.